| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.53B | 68.29B | 66.30B | 60.78B | 55.46B | 51.42B |
| Gross Profit | 18.44B | 20.69B | 17.45B | 16.19B | 14.60B | 16.72B |
| EBITDA | 6.62B | 7.20B | 6.28B | 6.11B | 5.77B | 6.89B |
| Net Income | 1.59B | 2.98B | 1.73B | 796.00M | 942.00M | 2.28B |
Balance Sheet | ||||||
| Total Assets | 91.24B | 93.81B | 89.42B | 90.07B | 85.05B | 75.13B |
| Cash, Cash Equivalents and Short-Term Investments | 31.93B | 34.70B | 30.25B | 33.47B | 28.31B | 21.21B |
| Total Debt | 45.15B | 46.48B | 46.34B | 44.28B | 41.29B | 32.39B |
| Total Liabilities | 54.72B | 55.00B | 53.37B | 52.48B | 48.76B | 39.38B |
| Stockholders Equity | 35.10B | 37.69B | 34.64B | 35.77B | 34.64B | 34.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.81B | 2.72B | 3.21B | 685.00M | -5.08B |
| Operating Cash Flow | 0.00 | 9.03B | 4.21B | 5.94B | 3.37B | 3.35B |
| Investing Cash Flow | 0.00 | 2.50B | -10.76B | -2.25B | -7.42B | -9.59B |
| Financing Cash Flow | 0.00 | -1.11B | -251.00M | 2.25B | 6.85B | 3.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 41.80% | |
73 Outperform | ¥480.28B | 13.35 | 8.51% | 2.25% | 2.19% | 23.96% | |
73 Outperform | ¥32.01B | 9.06 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
67 Neutral | ¥18.74B | 8.52 | ― | 3.46% | 4.11% | 3.43% | |
63 Neutral | ¥32.58B | 10.40 | ― | 1.90% | 3.00% | 74.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |